<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02753582</url>
  </required_header>
  <id_info>
    <org_study_id>SOD</org_study_id>
    <nct_id>NCT02753582</nct_id>
  </id_info>
  <brief_title>The Effect of SOD Enzyme on Frailty and HRQOL Among Indonesian Pre-frail Elderly: A Double Blind Randomized Controlled Trial</brief_title>
  <official_title>The Effect of Superoxide Dismutase (SOD) Enzyme on Frailty and Health Related Quality of Life Among Indonesian Pre-frail Elderly: A Double Blind Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indonesia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indonesia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective is to determine the effect of SOD enzyme on frailty and health related
      quality of life among Indonesian pre-frail elderly.

      The secondary objective is to determine the effect of SOD enzyme on anti-oxidant status,
      morbidity, and hospitalization among Indonesian pre-frail elderly.

      The study hypothesis:

        1. SOD enzyme can improve frailty status and health related quality of life among
           Indonesian pre-frail elderly.

        2. SOD enzyme can increase anti-oxidant serum status among Indonesian pre-frail elderly.

        3. SOD enzyme can decrease morbidity among Indonesian pre-frail elderly.

        4. SOD enzyme can decrease hospitalization events among Indonesian pre-frail elderly.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Study design: randomized double blind placebo controlled trial.

        2. Location and time of study: Geriatric Outpatient Clinic and Internal Medicine Outpatient
           Clinic in Cipto Mangunkusumo National Hospital Jakarta. Study will be conducted on April
           2016 to April 2017.

        3. Study subject: elderly outpatient (aged 60 years old or more) with pre-frail status, who
           visit the clinic for medical consultation.

        4. Data sampling: consecutive method.

        5. Sample size: 150 subjects (75 control group, 75 intervention group).

        6. Data collection: demographic data, frailty status, health related quality of life,
           anthropometric data, anti-oxidant serum status, hospitalization during intervention,
           morbidity, nutritional status, food intake, hand grip strength.

        7. Intervention: SOD+Gliadin in capsule with a dose of 250 mg twice a day for 24 weeks will
           be given to intervention group, while placebo group will be given placebo capsule
           (amylum).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">February 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frailty status</measure>
    <time_frame>6 months (24 weeks)</time_frame>
    <description>Measured by FI-40 item questionnaire.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Health related quality of life</measure>
    <time_frame>6 months (24 weeks)</time_frame>
    <description>Measured by EQ5D questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anti-oxidant serum status</measure>
    <time_frame>6 months (24 weeks)</time_frame>
    <description>Measured by erythrocyte antioxidant enzymes activity, i.e. superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morbidity</measure>
    <time_frame>6 months (24 weeks)</time_frame>
    <description>Measured by Cumulative Illness Rating Score (CIRS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalization</measure>
    <time_frame>6 months (24 weeks)</time_frame>
    <description>Observed hospitalization event during the study</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Pre-frail Elderly</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SOD+Gliadin capsule is given in a dosage of 250 mg twice a day, for 24 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo capsule is given in a dosage of 250 mg twice a day, for 24 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>SOD+Gliadin Capsule</intervention_name>
    <arm_group_label>Intervention</arm_group_label>
    <other_name>GLISODin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elderly aged 60 years or more with pre-frail condition

          -  Patients with SOD enzyme deficiency

          -  Willing to participate

        Exclusion Criteria:

          -  Patients with cognitive function impairment (AMT score &lt; 8)

          -  Patients with depression (Geriatric depression scale score &gt;= 10)

          -  Patients with history of cirrhotic hepatic disease or severe hepatic disease

          -  Patients with kidney function impairment

          -  Patients with gluten allergy and derivative products

          -  Patients consume other antioxidant and omega-3 supplement
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Siti Setiati, Prof, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Faculty of Medicine, Universitas Indonesia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Purwita Wijaya Laksmi, MD</last_name>
    <role>Study Director</role>
    <affiliation>Faculty of Medicine, Universitas Indonesia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kuntjoro Harimurti, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Medicine, Universitas Indonesia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rahmi Istanti, MARS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Medicine, Universitas Indonesia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Siti Setiati, Prof, MD, PhD</last_name>
    <phone>8138985588</phone>
    <phone_ext>+62</phone_ext>
    <email>s_setiati@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Purwita Wijaya Laksmi, MD</last_name>
    <phone>8161390993</phone>
    <phone_ext>+62</phone_ext>
    <email>pwlaksmi@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cipto Mangunkusumo National Hospital</name>
      <address>
        <city>Jakarta</city>
        <zip>10430</zip>
        <country>Indonesia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rahmi Istanti, MARS</last_name>
      <phone>8151974578</phone>
      <phone_ext>+62</phone_ext>
      <email>r_istanti@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <reference>
    <citation>Salomon JA, Wang H, Freeman MK, Vos T, Flaxman AD, Lopez AD, Murray CJ. Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet. 2012 Dec 15;380(9859):2144-62. doi: 10.1016/S0140-6736(12)61690-0. Erratum in: Lancet. 2013 Feb 23;381(9867):628.</citation>
    <PMID>23245606</PMID>
  </reference>
  <reference>
    <citation>Rodriguez-Ma√±as L, Fried LP. Frailty in the clinical scenario. Lancet. 2015 Feb 14;385(9968):e7-e9. doi: 10.1016/S0140-6736(14)61595-6. Epub 2014 Nov 6.</citation>
    <PMID>25468154</PMID>
  </reference>
  <reference>
    <citation>Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013 Mar 2;381(9868):752-62. doi: 10.1016/S0140-6736(12)62167-9. Epub 2013 Feb 8. Review. Erratum in: Lancet. 2013 Oct 19;382(9901):1328.</citation>
    <PMID>23395245</PMID>
  </reference>
  <reference>
    <citation>Laksmi PW. Frailty syndrome: an emerging geriatric syndrome calling for its potential intervention. Acta Med Indones. 2014 Jul;46(3):173-4.</citation>
    <PMID>25348178</PMID>
  </reference>
  <reference>
    <citation>Setiati S, Harimurti K, Dewiasty E, Istanti R, Mupangati YM, Ngestiningsih D, Purwoko Y, Aryana IS, Kuswardhani RT, Pramantara ID, Apandi M, Dwipa L, Budiningsih F, Dinda R, Widajanti N, Siburian P, Sunarti S, Umar S, Jim E, Junaidi-Ar. Profile of food and nutrient intake among Indonesian elderly population and factors associated with energy intake: a multi-centre study. Acta Med Indones. 2013 Oct;45(4):265-74.</citation>
    <PMID>24448330</PMID>
  </reference>
  <reference>
    <citation>Setiati S. Vitamin D status among Indonesian elderly women living in institutionalized care units. Acta Med Indones. 2008 Apr;40(2):78-83.</citation>
    <PMID>19054885</PMID>
  </reference>
  <reference>
    <citation>Gill TM, Gahbauer EA, Allore HG, Han L. Transitions between frailty states among community-living older persons. Arch Intern Med. 2006 Feb 27;166(4):418-23.</citation>
    <PMID>16505261</PMID>
  </reference>
  <reference>
    <citation>Sumantri S, Setiati S, Purnamasari D, Dewiasty E. Relationship between metformin and frailty syndrome in elderly people with type 2 diabetes. Acta Med Indones. 2014 Jul;46(3):183-8.</citation>
    <PMID>25348180</PMID>
  </reference>
  <reference>
    <citation>Wang CP, Lorenzo C, Espinoza SE. Frailty Attenuates the Impact of Metformin on Reducing Mortality in Older Adults with Type 2 Diabetes. J Endocrinol Diabetes Obes. 2014;2(2). pii: 1031.</citation>
    <PMID>25506599</PMID>
  </reference>
  <reference>
    <citation>Kobayashi S, Asakura K, Suga H, Sasaki S; Three-generation Study of Women on Diets and Health Study Groups. Inverse association between dietary habits with high total antioxidant capacity and prevalence of frailty among elderly Japanese women: a multicenter cross-sectional study. J Nutr Health Aging. 2014 Nov;18(9):827-39. doi: 10.1007/s12603-014-0478-4.</citation>
    <PMID>25389961</PMID>
  </reference>
  <reference>
    <citation>Cloarec M, Caillard P, Provost JC, Dever JM, Elbeze Y, Zamaria N. GliSODin, a vegetal sod with gliadin, as preventative agent vs. atherosclerosis, as confirmed with carotid ultrasound-B imaging. Eur Ann Allergy Clin Immunol. 2007 Feb;39(2):45-50.</citation>
    <PMID>17441415</PMID>
  </reference>
  <reference>
    <citation>Ensrud KE, Ewing SK, Taylor BC, Fink HA, Cawthon PM, Stone KL, Hillier TA, Cauley JA, Hochberg MC, Rodondi N, Tracy JK, Cummings SR. Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med. 2008 Feb 25;168(4):382-9. doi: 10.1001/archinternmed.2007.113.</citation>
    <PMID>18299493</PMID>
  </reference>
  <reference>
    <citation>Peng C, Wang X, Chen J, Jiao R, Wang L, Li YM, Zuo Y, Liu Y, Lei L, Ma KY, Huang Y, Chen ZY. Biology of ageing and role of dietary antioxidants. Biomed Res Int. 2014;2014:831841. doi: 10.1155/2014/831841. Epub 2014 Apr 3. Review.</citation>
    <PMID>24804252</PMID>
  </reference>
  <reference>
    <citation>Bjelakovic G, Nikolova D, Gluud C. Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm? PLoS One. 2013 Sep 6;8(9):e74558. doi: 10.1371/journal.pone.0074558. eCollection 2013.</citation>
    <PMID>24040282</PMID>
  </reference>
  <reference>
    <citation>Persson T, Popescu BO, Cedazo-Minguez A. Oxidative stress in Alzheimer's disease: why did antioxidant therapy fail? Oxid Med Cell Longev. 2014;2014:427318. doi: 10.1155/2014/427318. Epub 2014 Jan 5. Review.</citation>
    <PMID>24669288</PMID>
  </reference>
  <reference>
    <citation>Flores-Mateo G, Carrillo-Santisteve P, Elosua R, Guallar E, Marrugat J, Bleys J, Covas MI. Antioxidant enzyme activity and coronary heart disease: meta-analyses of observational studies. Am J Epidemiol. 2009 Jul 15;170(2):135-47. doi: 10.1093/aje/kwp112. Epub 2009 May 22.</citation>
    <PMID>19465742</PMID>
  </reference>
  <reference>
    <citation>Laosa O, Alonso C, Castro M, Rodriguez-Manas L. Pharmaceutical interventions for frailty and sarcopenia. Curr Pharm Des. 2014;20(18):3068-82. Review.</citation>
    <PMID>24079768</PMID>
  </reference>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 12, 2016</study_first_submitted>
  <study_first_submitted_qc>April 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 28, 2016</study_first_posted>
  <last_update_submitted>May 27, 2016</last_update_submitted>
  <last_update_submitted_qc>May 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 30, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indonesia University</investigator_affiliation>
    <investigator_full_name>Siti Setiati</investigator_full_name>
    <investigator_title>Prof. MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Elderly, pre-frail, SOD</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Superoxide Dismutase</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

